Dava Home

Sale!
, , ,

Silodosia M 25 – Mirabegron 25 mg (ER) & Silodosin 8 mg Tablets – 1 × 10 Tablets

Original price was: ₹470.00.Current price is: ₹159.99.

Silodosia M 25 by Steris Healthcare is a high-performance, dual-action urological tablet combining the selective alpha-blocker Silodosin (8 mg) with Extended Release Mirabegron (25 mg). Specifically engineered for comprehensive bladder and prostate management, it pairs a fast-acting compound that relaxes the prostate lining with a premium bladder-calming agent to ease sudden urinary urgency and restore a smooth, controlled flow.

Add to Wishlist
Add to Wishlist

Silodosia M 25 Tablets provide an established, clinically unified combination urological therapy carefully developed for the synchronized management of urinary storage and voiding symptoms driven by Benign Prostatic Hyperplasia (BPH) and secondary Overactive Bladder (OAB). In adult urological care, an enlarged prostate often blocks the bladder outlet, while the bladder muscle itself becomes hyper-reactive over time due to constant obstruction stress. This causes a dual frustration: a weak, hesitant urinary stream paired with sudden, uncontrollable urges to urinate. This advanced formulation combines two complementary receptor-targeted tracks within a single daily unit to safely open structural passages and steady bladder storage cycles.

The formula operates dynamically across two distinct physiological fronts:

  • Silodosin (8 mg): A highly potent, next-generation alpha-blocker with extreme structural selectivity for $\alpha_{1A}$-adrenergic receptors located predominantly in the human prostate, bladder neck, and prostatic urethra. By blocking these localized receptors, it causes rapid smooth muscle relaxation in the bladder exit tract, reducing outflow resistance and vastly improving urine flow speed without causing broader systemic vascular shifts.

  • Mirabegron (25 mg ER): A highly selective $\beta_3$-adrenergic receptor agonist presented in an Extended Release (ER) matrix. It functions by binding to $\beta_3$ receptors on the detrusor muscle of the bladder wall, stimulating adenylate cyclase and increasing intracellular cyclic adenosine monophosphate (cAMP) loops. This mechanical action relaxes the bladder muscle during its storage phase, maximizing its volumetric storage capacity and actively calming sudden, premature contraction misfires that trigger panic urgency.

Key Benefits

  • Complete Dual-Action Relief: Simultaneously opens a restricted prostate passage and relaxes an irritable, hyper-reactive bladder muscle.

  • High Uro-Selectivity Profile: Silodosin’s targeted receptor affinity minimizes the risk of sudden blood pressure drops or dizziness common to older alpha-blockers.

  • Extended Release Stability: Mirabegron’s gradual dissolution provides smooth, 24-hour calm to the bladder, significantly reducing disruptive nighttime bathroom trips (nocturia).

  • Improves Stream and Control: Restores a strong, continuous urinary stream while helping you comfortably delay the urge to void.

  • Trusted Quality: Manufactured under the strict pharmaceutical benchmarks of Steris Healthcare, ensuring precise active ingredient stability and delivery.

Directions for Use

  • Take exactly as directed by your urologist or primary care physician.

  • Swallow the tablet whole with a full glass of water. Do not crush, break, or chew it, as doing so will instantly destroy the specialized extended-release matrix.

  • Silodosia M 25 must strictly be taken orally once daily with or immediately after a main meal (ideally the same meal every day, such as breakfast or dinner) to ensure optimal intestinal absorption and safe plasma tracking trends.

Safety & Precautions

  • Do not modify your dose or stop taking this medication suddenly without specialist clearance, as urinary retention or severe urgency loops can return sharply.

  • Retrograde Ejaculation Note: Silodosin relaxes the smooth muscle of the reproductive tract, which frequently leads to a benign condition known as retrograde ejaculation (semen traveling into the bladder instead of exiting). This is entirely harmless, fully reversible upon stopping the medication, and does not affect sexual pleasure tracking.

  • Intraoperative Floppy Iris Syndrome (IFIS): If you are scheduled for cataract eye surgery, inform your ophthalmic surgeon well in advance that you are taking this medication, as alpha-blockers can alter iris structural behaviors during the procedure.

  • Inform your specialist before initialization if you have an underlying history of severe kidney disease, liver impairment, or severe uncontrolled high blood pressure.

  • Keep out of reach of children.

Storage

  • Store in a cool, dry place below 30°C.

  • Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.

  • Keep the tablets safely stored inside their original protective packaging configuration until the exact moment of consumption to shield them from ambient humidity tracks.

Weight 0.004 g
Dimensions 10 × 5 × 2.5 cm
Composition

Mirabegron 25 mg ER & Silodosin 8 mg

Dosage Form

Extended Release Tablet

Pack Size

1 × 10 Tablets

Uses

Treats lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) / enlarged prostate in men.
Manages symptoms of Overactive Bladder (OAB) such as sudden urinary urgency, increased frequency, and urge incontinence.
Improves weak urinary streams, hesitant initiation, and incomplete bladder emptying grids by relaxing tight urological passages.

Scroll to Top